| [1] 李道娟, 李倩, 贺宇彤. 结直肠癌流行病学趋势.肿瘤防治研究,2015,42(3):305-310. Li D J, Li Q, He Y T.Epidemiological trends of colorectal cancer. Cancer Res Prev Treat,2015,42(3):305-310.
[2] Li Z Q, Tang M, Ling B, et al. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.J Mol Med,2014, 92(3):291-303.
[3] De Petris L, Orre L M, Kanter L, et al. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cance. Lung Cancer,2009, 63(3):410-417.
[4] Komatsu K, Andoh A, Ishiguro S, et al. Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res,2000,6(1):172-177.
[5] Wang X H, Zhang L H, Zhong X Y, et al.. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. Am J Pathol,2010,177(2):586-597.
[6] Vimalachandran D, Greenhalf W, Thompson C, et al. High nuclear S100A6 (calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res,2005, 65(8):3218-3225.
[7] Komatsu K, Kobune-Fujiwara Y, Andoh A, et al. Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer, 2000, 83(6):769-774.
[8] Kuznicki J, Kordowska J, Puzianowska M, et al. Calcyclin as a marker of human epithelial cells and fibroblasts.Exp Cell Res, 1992,200(2):425-430.
[9] Jurewicz E, Góral A, Filipek A. S100A6 is secreted from Wharton's jelly mesenchymal stem cells and interacts with integrin β1.The International Journal of Biochemistry & Cell Biology,2014,55:298-303.
[10] Leclerc E, Fritz G, Weibel M, et al. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem,2007,282(43):31317-31331.
[11] Wiesawa L, Ukasz P S, Anna F. S100A6-new facts and features.Biochemical and Biophysical Research Communications,2009,390(4):1087-1092.
[12] Polakis P. The many ways of Wnt in cancer . Current Opinion in Genetics & Development,2007,17(5):45-51.
[13] Suriano G, Vrcelj N, Senz J, et al. Beta-catenin(CTNNB1)geneam plification:a new mechanism of protein over expression in cancer .Genes Chromosomes Cancer,2005,42(3):238-246.
[14] Kilanczyk E, Graczyka A, Ostrowskab H, et al. S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells.Cell Calcium, 2012, 51(6): 470-477.
[15] 黎玉叶, 李星星, 孙双双, 等. S100A6蛋白对细胞中β-catenin水平的影响及可能机制.中国生物工程杂志,2011,31(11) :18-23. Li Y Y, Li X X, Sun S S, et al. Effects and possible mechanism of protein S100A6 on β-catenin.China Biotechnology,2011,31(11) :18-23.
[16] 邹正渝, 陈英华, 孙双双, 等. hS100A6抑制卵巢癌细胞HO8910和HO8910PM增殖促进凋亡并上调其Wnt/β-catenin活性.第三军医大学学报, 2012,34(3):214-218. Zou Z Y, Chen Y H, Sun S S, et al. hS100A6inhibits proliferation,induces apoptosis andup-regulates Wnt/ β-catenin activity in ovarian cancer cell lines HO8910 and HO8910PM. J Third Mil Med Univ, 2012,34(3):214-218.
[17] 陈英华, 孙双双, 卫佳, 等. 外源性S100A6 对黑色素瘤 B16细胞增殖、凋亡的影响及其机制. 中国生物制品学杂志,2012,25(3):304-308. Chen Y H, Sun S S, Wei J, et al. Effect of exogenous S100A6 on proliferation and apoptosis of melanoma B16 cells and relevant mechanism. Chin J Biologicals,2012,25(3):304-308.
[18] 武睿, 段亮, 叶立伟, 等. S100A6上调人乳腺癌细胞系MCF-7中β-catenin及其机制. 基础医学与临床,2013,33(7):793-798. Wu R, Duan L, Ye L W, er al. S100A6 upregulates β-catenin and its mechanism in human breast cancer cell MCF-7. Basic&Clinical Medicine,2013,33(7):793-798.
[19] 邹正渝, 王海燕, 黎玉叶, 等. 重组hS100A6蛋白的原核表达及其对人骨肉瘤细胞系143B的生物学作用.中国生物工程杂志,2012,32(12):1-7. Zou Z Y, Wang H Y, Li Y Y, et al. Prokaryotic expression of recombinant protein hS100A6 and its biological effects on human osteosarcoma cell line 143B. China Biotechnology,2012,32(12):1-7.
[20] Kuznicki J, Filipek A. Purification and properties of a novel Ca2+-bindingprotein(10.5kDa) from Ehrlich-ascites-tumour cells.Biochem J, 1987, 247( 3) : 663-667.
[21] Duan L, Wu R, Zou Z Y, et al. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways. Int J Oncol, 2014, 44(3): 781-790.
[22] 赖天霞, 苗静琨, 何焕玲, 等. 钙结合蛋白S100A6 对Wnt/ β-catenin信号途径的影响.中华肿瘤杂志,2008,30(1):12-15. Lai T X, Miao J K, He H L,et al. Effects of Ca2+-binding protein S100A6 on Wnt/β-catenin signaling pathway. Chinese Journal of Oncology,2008,30(1):12-15.
[23] 时杰, 王琳, 胡丽华. Wnt信号传导通路与Cadherin/Catenin复合体的关联及其在肿瘤发生中的作用.世界华人消化杂志, 2005,13(2):250-254. Shi J, Wang L, Hu L H. The association between Wnt signaling pathway and Cadherin/Catenin complex and its effect on tumorigenesis. World Chin J Digestol, 2005, 13(2):250-254.
[24] Kuphal F,Behrens J. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Experimental Cell Research, 2006, 312(4): 457-467. |
